In colorectal cancer cells, EGF decreases expression of the fatty acid transporter intestinal fatty acid binding protein (I-FABP) and fatty acid uptake (Darimont et al., 1999) while increasing FAS expression (Wei et al., 2023), and intracellular TG and cholesterol content (Liang et al., 2002). This evidence concerns the gene EGF and colorectal cancer.